In: Nursing
Medications affecting coagulation
Coumadin |
Heparin |
Lovenox |
|
Mode of Action |
|||
Indications |
|||
Dosage/Route |
|||
Side Effects |
|||
Labs to Monitor |
|||
Antidote |
|||
Patient teaching |
Coumadin |
Heparin |
|
Mode of Action |
It produces its anticoagulant affect by interfering with the Vitamin K cycle. |
Heparin exerts parts of its anticoagulant activity through interaction with antithrombin antithrombin binds specifically to a pentsaccharide in heparin binding to heparin induced a conformational change in the antithrombin, which accelerate enzyme inhibition |
Indication |
Prophylaxis and treatment of Venous thrombosis, Pulmonary embolism, thromboembolic complications associated with atrial fibrillation (AF) and/or cardiac valve replacement. Reduction in the risk of death, recurrent myocardial infarction (MI), and stroke. |
Treatment of acute and chronic consumption coagulopathies
(disseminated intravascular coagulation); Reduction in the risk of death, recurrent myocardial infarction (MI), and stroke. |
Dosage and Route |
Tablet / Oral route – 1mg,2mg,2.5mg,3mg,4mg,5mg,6mg,7.5mg and 10 mg Injection/ Intravenous route: 5 mg, lyophilized powder in a single-dose vial. |
Heparin sodium is not effective by oral administration and should be given by intermittent intravenous injection, after dilution in 50 or 100 mL of 5% Dextrose Injection, USP or 0.9% Sodium Chloride Injection, USP, or by intravenous infusion. |
Side effects |
Hemorrhage, Hypersensitivity, Tissue Necrosis, Calciphylaxis ,Acute Kidney Injury , Limb Ischemia, Necrosis, and Gangrene
|
Hemorrhage, Hypersensitivity, thromboembolic complications such as skin necrosis, gangrene of the extremities that may lead to amputation, myocardial infarction, pulmonary embolism, stroke and possibly death.
|
Labs to monitor |
Complete blood picture |
SGOT,SGPT Periodic platelet counts, hematocrits and tests for occult blood in stool are recommended during the entire course of heparin therapy |
Antidote |
Oral or Parenteral Vitamin K1 |
Protamine sulfate (1% solution) by slow infusion will neutralize heparin sodium. No more than 50 mg should be administered, very slowlyin any 10 minute period. Each mg of protamine sulfate neutralizes approximately 100 USP heparin units. |
Patient Teaching |
Instruct the patient to
|
Instruct the patient to
|